Clinical Trials Search Results

  • Resize font
  • Print
  • Email
  • Facebook
  • Twitter
  • Google+
  • Pinterest

Initial search results include only NCI-sponsored clinical trials. To search all trials, click the "REFINE SEARCH" button, scroll down to the Trial ID/Sponsor section and select the "All" check box in the Sponsor of Trial section.

View Content for:
Display:
?
Cancer Type/Condition:  Cancer- and cancer treatment-related conditions
Stage/Subtype:  neuropathy
Trial Type:  Supportive care
Trial Status:  Closed
Sponsor of Trial:  NCI
Results 1-18 of 18 for your search:
Start Over
Gabapentin in Treating Peripheral Neuropathy in Cancer Patients Undergoing Chemotherapy
Phase: Phase III
Type: Supportive care
Status: Completed
Age: 18 and over
Sponsor: NCI, Other
Protocol IDs: CDR0000069098, NCCTG-N00C3, NCCTG-CCC-0020, NCI-P01-0196, NCT00027963
Amifostine in Treating Peripheral Neuropathy in Patients Who Have Received Chemotherapy for Cancer
Phase: Phase III
Type: Supportive care
Status: Completed
Age: 18 and over
Sponsor: NCI, Other
Protocol IDs: CDR0000285700, GOG-0192, NCT00058071
Alpha-Lipoic Acid in Preventing Peripheral Neuropathy in Patients Receiving Chemotherapy for Cancer
Phase: Phase III
Type: Supportive care
Status: Completed
Age: Not specified
Sponsor: NCI, Other
Protocol IDs: CDR0000403155, MDA-CCC-0327, MDA-2004-0728, 2004-0728, NCI-2009-00636, 3 U10 CA045809-15S1, NCT00112996
Glutamic Acid in Reducing Nerve Damage Caused by Vincristine in Young Patients With Cancer
Phase: Phase III
Type: Supportive care
Status: Completed
Age: 3 to 20
Sponsor: NCI, Other
Protocol IDs: SCUSF 0402, ACCL 0731, 5U10CA081920-11, HLMCC-0402, NCT00369564
Topical Amitriptyline and Ketamine Cream in Treating Peripheral Neuropathy Caused by Chemotherapy in Patients With Cancer
Phase: Phase III
Type: Supportive care
Status: Closed
Age: 18 and over
Sponsor: NCI, Other
Protocol IDs: CDR0000543103, U10CA037420, URCC-0605, URCC-07004, NCT00471445
Duloxetine in Treating Peripheral Neuropathy Caused by Chemotherapy in Patients With Cancer
Phase: Phase III
Type: Supportive care
Status: Closed
Age: 25 and over
Sponsor: NCI, Other
Protocol IDs: CDR0000553389, CALGB-170601, NCT00489411
Baclofen-Amitriptyline Hydrochloride-Ketamine Gel in Treating Peripheral Neuropathy Caused by Chemotherapy in Patients With Cancer
Phase: Phase III
Type: Supportive care
Status: Closed
Age: 18 and over
Sponsor: NCI, Other
Protocol IDs: CDR0000560732, NCCTG-N06CA, N06CA, NCT00516503
S0715: Acetyl-L-Carnitine in Preventing Neuropathy in Women With Stage I, Stage II, or Stage IIIA Breast Cancer Undergoing Chemotherapy
Phase: Phase III
Type: Biomarker/Laboratory analysis, Supportive care, Treatment
Status: Completed
Age: 18 and over
Sponsor: NCI, Other
Protocol IDs: CDR0000617081, S0715, U10CA037429, SWOG-S0715, NCT00775645
Glutathione in Preventing Peripheral Neuropathy Caused by Paclitaxel and Carboplatin in Patients With Ovarian Cancer, Fallopian Tube Cancer, and/or Primary Peritoneal Cancer
Phase: Phase III
Type: Biomarker/Laboratory analysis, Supportive care
Status: Closed
Age: 18 and over
Sponsor: NCI, Other
Protocol IDs: CDR0000654097, NCCTG-N08CA, N08CA, NCT00979082
Calcium Gluconate and Magnesium Sulfate in Preventing Neurotoxicity in Patients With Colon Cancer or Rectal Cancer Receiving Oxaliplatin-Based Combination Chemotherapy
Phase: Phase III
Type: Biomarker/Laboratory analysis, Supportive care, Treatment
Status: Closed
Age: 18 and over
Sponsor: NCI, Other
Protocol IDs: CDR0000669660, NCCTG-N08CB, N08CB, NCT01099449
Docetaxel and Cisplatin With or Without Dimesna in Treating Patients With Stage IIIB or Stage IV Non-Small Cell Lung Cancer
Phase: Phase II
Type: Supportive care, Treatment
Status: Completed
Age: 18 and over
Sponsor: NCI, Other
Protocol IDs: CDR0000350089, U10CA031946, CALGB-30303, NCT00077311
Electrical Stimulation Therapy Using the MC5-A Scrambler in Reducing Peripheral Neuropathy Caused by Chemotherapy
Phase: Phase II
Type: Supportive care
Status: Completed
Age: 18 and over
Sponsor: NCI, Other
Protocol IDs: CDR0000644516, MCV-MCC-12110, MCC-12110, NCT00952848
Prevention of Treatment Induced Neuropathy in Multiple Myeloma
Phase: Phase II
Type: Supportive care
Status: Closed
Age: 18 and over
Sponsor: NCI, Other
Protocol IDs: 2006-0022, NCI-2011-00247, 1P01CA124787-01, NCT01283997
MC5-A Scrambler Therapy in Reducing Peripheral Neuropathy Caused by Chemotherapy
Phase: Phase II
Type: Supportive care
Status: Completed
Age: 18 and over
Sponsor: NCI, Other
Protocol IDs: MC10C8, NCI-2011-00109, 10-007874, NCT01290224
Quality of Life, Employment, and Informal Care Costs in Women Who Are Receiving Chemotherapy for Breast Cancer
Phase: No phase specified
Type: Natural history/Epidemiology, Supportive care
Status: Closed
Age: 18 and over
Sponsor: NCI, Other
Protocol IDs: CDR0000433266, CALGB-70301, NCT00115505
Nerve Changes in Patients Who Are Undergoing Chemotherapy or Biological Therapy for Cancer
Phase: No phase specified
Type: Supportive care
Status: Completed
Age: 21 to 85
Sponsor: NCI, Other
Protocol IDs: CASE13Z04, P30CA043703, CASE-120411, NCT00281853
Cryotherapy in Preventing Peripheral Neuropathy and Nail Toxicity in Patients With Breast Cancer Who Are Receiving Paclitaxel
Phase: No phase specified
Type: Supportive care
Status: Closed
Age: 18 and over
Sponsor: NCI, Other
Protocol IDs: NU 10CC03, NCI-2010-02105, STU00033028, NCT01243541
Heavy Metal Exposure in Predicting Peripheral Neuropathy in Patients With Stage I-III Breast Cancer Undergoing Chemotherapy
Phase: No phase specified
Type: Biomarker/Laboratory analysis, Supportive care
Status: Completed
Age: 18 and over
Sponsor: NCI, Other
Protocol IDs: ERP-BR-059, NCI-2013-01957, IRB#10-039, BR-059, P30CA006927, NCT01982591
Start Over